Treatment.com AI Engages Market Maker
Treatment.com AI (OTC: TREIF) has engaged Independent Trading Group (ITG) as its market maker starting July 29, 2025. The agreement aims to maintain reasonable market conditions and enhance the liquidity of Treatment's common shares across all trading venues.
Under the agreement terms, ITG will receive CAD $5,500 monthly compensation, with an initial one-month term that automatically renews unless terminated with 30 days' notice. No performance factors, shares, or options are included in the compensation package. ITG, established in 1992, is a Toronto-based CIRO dealer-member specializing in market making and liquidity provision services.
Treatment.com AI (OTC: TREIF) ha incaricato Independent Trading Group (ITG) come market maker a partire dal 29 luglio 2025. L'accordo mira a mantenere condizioni di mercato ragionevoli e a migliorare la liquidità delle azioni ordinarie di Treatment su tutte le piattaforme di negoziazione.
Secondo i termini dell'accordo, ITG riceverà un compenso mensile di 5.500 CAD, con una durata iniziale di un mese che si rinnova automaticamente salvo disdetta con preavviso di 30 giorni. Il pacchetto di compensi non include fattori di performance, azioni o opzioni. ITG, fondata nel 1992, è un dealer membro CIRO con sede a Toronto, specializzato in market making e servizi di fornitura di liquidità.
Treatment.com AI (OTC: TREIF) ha contratado a Independent Trading Group (ITG) como su market maker a partir del 29 de julio de 2025. El acuerdo tiene como objetivo mantener condiciones de mercado razonables y mejorar la liquidez de las acciones ordinarias de Treatment en todos los mercados de negociación.
Según los términos del acuerdo, ITG recibirá una compensación mensual de 5,500 CAD, con un plazo inicial de un mes que se renueva automáticamente a menos que se termine con un aviso de 30 días. El paquete de compensación no incluye factores de rendimiento, acciones ni opciones. ITG, fundada en 1992, es un dealer miembro CIRO con sede en Toronto, especializado en market making y en la provisión de liquidez.
Treatment.com AI (OTC: TREIF)는 2025년 7월 29일부터 Independent Trading Group(ITG)를 마켓 메이커로 선정했습니다. 이 계약은 합리적인 시장 상황을 유지하고 Treatment의 보통주 유동성을 모든 거래소에서 향상시키는 것을 목표로 합니다.
계약 조건에 따라 ITG는 월 5,500 캐나다 달러의 보상을 받으며, 초기 계약 기간은 한 달이고 30일 사전 통지 없이는 자동으로 갱신됩니다. 보상 패키지에는 성과 요소, 주식 또는 옵션이 포함되어 있지 않습니다. 1992년에 설립된 ITG는 토론토에 본사를 둔 CIRO 딜러 회원으로, 마켓 메이킹 및 유동성 제공 서비스를 전문으로 합니다.
Treatment.com AI (OTC : TREIF) a engagé Independent Trading Group (ITG) comme teneur de marché à partir du 29 juillet 2025. L'accord vise à maintenir des conditions de marché raisonnables et à améliorer la liquidité des actions ordinaires de Treatment sur toutes les plateformes de négociation.
Selon les termes de l'accord, ITG recevra une rémunération mensuelle de 5 500 CAD, avec une durée initiale d'un mois renouvelable automatiquement sauf résiliation avec un préavis de 30 jours. Aucun facteur de performance, action ou option n'est inclus dans le package de rémunération. ITG, fondée en 1992, est un membre dealer CIRO basé à Toronto, spécialisé dans le market making et la fourniture de liquidité.
Treatment.com AI (OTC: TREIF) hat Independent Trading Group (ITG) ab dem 29. Juli 2025 als Market Maker beauftragt. Das Ziel der Vereinbarung ist es, vernünftige Marktbedingungen aufrechtzuerhalten und die Liquidität der Stammaktien von Treatment an allen Handelsplätzen zu verbessern.
Nach den Vertragsbedingungen erhält ITG eine monatliche Vergütung von 5.500 CAD, mit einer anfänglichen Laufzeit von einem Monat, die sich automatisch verlängert, sofern sie nicht mit einer Frist von 30 Tagen gekündigt wird. Das Vergütungspaket beinhaltet keine leistungsbezogenen Faktoren, Aktien oder Optionen. ITG, gegründet 1992, ist ein in Toronto ansässiges CIRO-Mitglied und spezialisiert auf Market Making und Liquiditätsbereitstellung.
- Potential improvement in stock liquidity through professional market making services
- Partnership with established market maker (ITG) with over 30 years of experience
- Additional monthly expense of CAD $5,500 for market making services
Vancouver, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; 939: FRA) has engaged the services of Independent Trading Group ("ITG") pursuant to an agreement dated and starting on July 29, 2025 (the “Agreement”) to provide market-making services in accordance with Canadian Securities Exchange (“CSE”) policies. ITG will trade shares of the Company on the CSE and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Company's common shares.
Under the terms of the Agreement, ITG will receive compensation of CAD
Independent Trading Group (ITG) Inc. is a Toronto based CIRO dealer-member that specializes in market making, liquidity provision, agency execution, ultra-low latency connectivity, and bespoke algorithmic trading solutions. Established in 1992, with a focus on market structure, execution and trading, ITG has leveraged its own proprietary technology to deliver high quality liquidity provision and execution services to a broad array of public issuers and institutional investors.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). With more than ~10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and enables greater consistency in quality of patient support. Treatment’s GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment’s products and services: www.treatment.com or email: info@treatment.com
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statements
This news release contains forward-looking statements relating to the future operations of Treatment and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
FAQ
What is the purpose of Treatment.com AI (TREIF) engaging a market maker?
How much will Treatment.com AI (TREIF) pay ITG for market making services?
What is the duration of Treatment.com AI's market making agreement with ITG?
Who is Independent Trading Group (ITG) and what services do they provide?
Will ITG receive any shares or performance-based compensation from Treatment.com AI?
